biomea news - Search News

Biomea, type 2 diabetes

US FDA lifts clinical hold on Biomea's diabetes trials after safety review

The U.S. Food and Drug Administration lifted a clinical hold on Biomea Fusion's ongoing studies of its experimental drug for type 1 and type 2 diabetes, the drug developer said on Thursday. The regulator had placed a hold on two trials of its lead drug,

Business Insider · 7h

Biomea Fusion : FDA Lifts Clinical Hold On BMF-219 For Type 1 And Type 2 Diabetes Trials; Stock Up

Biomea Fusion Inc. (BMEA) announced that the U.S. Food and Drug Administration has lifted the clinical hold on the company's ongoing

MarketWatch · 17h

Biomea Fusion: FDA Lifts Hold on Diabetes-Treatment Trials

Biomea Fusion said the Food and Drug Administration lifted its clinical hold on continuing clinical trials of the company's diabetes drug.

Hosted on MSN · 16h

US FDA lifts clinical hold on Biomea's diabetes trials

Biomea Fusion said on Thursday the U.S. Food and Drug Administration lifted a clinical hold on ongoing studies of its experimental drug for type 1 and 2 diabetes, sending its shares up 6.9%. The decision comes as a boon for the company as the regulator placed a hold on two trials of its lead drug,

Finanznachrichten · 1h

Biomea Fusion, Inc.: FDA Lifts Clinical Hold on BMF-219 in Type 2 and Type 1 Diabetes Trials

Biomea Fusion, Inc. ("Biomea" or the "Company") (Nasdaq: BMEA), a clinical-stage biopharmaceutical company dedicated to discovering and developing

Biomea Fusion Hold Rating: FDA Clearance and Increased Price Target Amid Cautious Optimism

Barclays analyst Peter Lawson has reiterated their neutral stance on BMEA stock, giving a Hold rating yesterday. Peter Lawson has given his ...

13h

Approvals News | Today's Latest Stories | Reuters

Reuters.com is your online source for the latest news stories and current events, ensuring our readers up to date with any ...

devdiscourse14h

Current Updates: Major Developments in Health Sector

This summary highlights major health news, including Bavarian Nordic's UNICEF agreement for mpox vaccines, Pfizer's ...

Biomea Fusion, Inc. May Have Violated Securities Laws And The Schall Law Firm Urges Shareholder Participation In An Inquiry

NDAQ:BMEA) Biomea Fusion, Inc. May Have Violated Securities Laws And The Schall Law Firm Urges Shareholder Participation In An Inquiry ...

bovnews8d

Why Biomea Fusion Inc (BMEA) Stock is Currently 13.47% Above from Its 20-Day SMA?

Biomea Fusion Inc (BMEA) stock saw a modest uptick, ending the day at $8.26 which represents a slight increase of $0.28 or 3.51% from the prior close of $7.98. The stock opened at $8.03 and touched a ...

Wall Street Journal28d

Biomea Fusion Inc.

The Price to Earnings (P/E) ratio, a key valuation measure, is calculated by dividing the stock's most recent closing price by the sum of the diluted earnings per share from continuing operations ...

Stockhouse3d

Biomea Fusion, Inc. May Have Violated Securities Laws And The Schall Law Firm Urges Shareholders To Join An Inquiry

LOS ANGELES, CA / ACCESSWIRE / September 23, 2024 / The Schall Law Firm, a national shareholder rights litigation firm, announces that it is investigating claims on behalf of investors of Biomea ...

Truist Financial Issues a Hold Rating on Biomea Fusion (BMEA)

Truist Financial analyst Srikripa Devarakonda assigned a Hold rating to the stock today. The company’s shares closed yesterday at $8.71.

Results that may be inaccessible to you are currently showing.

Hide inaccessible results